Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Three decades of allogeneic bone marrow transplants at the Princess Margaret Hospital.

Tytuł:
Three decades of allogeneic bone marrow transplants at the Princess Margaret Hospital.
Autorzy:
Messner HA; Princess Margaret Hospital, Toronto, Ontario, Canada.
Curtis JE
Lipton JL
Meharchand JM
Minden MD
Panzarella A
Źródło:
Clinical transplants [Clin Transpl] 1999, pp. 289-94.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: Los Angeles, Calif. : UCLA Tissue Typing Laboratory, c1986-c2016
MeSH Terms:
Bone Marrow Transplantation/*statistics & numerical data
Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*therapy
Leukemia, Myeloid, Acute/*therapy
Bone Marrow Transplantation/mortality ; Bone Marrow Transplantation/physiology ; Cause of Death ; Follow-Up Studies ; Graft Survival ; Hematopoietic Stem Cells/cytology ; Humans ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/radiotherapy ; Leukemia, Myeloid, Acute/radiotherapy ; Neoplasms, Second Primary/epidemiology ; Ontario ; Palliative Care ; Postoperative Complications/classification ; Postoperative Complications/epidemiology ; Quality of Life ; Retrospective Studies ; Risk Assessment ; Survival Rate ; Time Factors ; Transplantation, Homologous ; Treatment Outcome ; Whole-Body Irradiation
Entry Date(s):
Date Created: 20001020 Date Completed: 20001115 Latest Revision: 20071115
Update Code:
20240104
PMID:
11038648
Czasopismo naukowe
A total of 1,122 patients with various hemopoietic disorders were transplanted at the Princess Margaret Hospital since 1970. The majority suffered from acute or chronic myeloid leukemia. Improvements in support strategies permitted a gradual escalation of the upper age limit for transplant candidates and resulted in better survival. The overall survival at 10 years of all patients transplanted consecutively either before or after 1986 increased from 30 to 50%. This change was observed independent of other transplant related risk factors and is predominantly attributable to the use of cyclosporine and ganciclovir. An improvement of similar magnitude was seen for transplant recipients presenting with good risk features. The 10-year survival of patients with acute and chronic myeloid leukemia transplanted from a fully matched sibling donor in first complete remission or first chronic phase increased from 40 to approximately 70%. The quality of life of surviving patients may not return to normal but appears to improve with time after the transplant.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies